Intraocular pressure (IOP) measurement is the cornerstone of the management of glaucoma patients. The gold standard for assessing IOP is Goldmann applanation tonometry (GAT). Recently, the dynamic contour tonometer (DCT) has become available. While both devices provide reliable IOP measurements, the results are not interchangeable. DCT has the advantage of measuring an additional parameter: ocular pulse amplitude (OPA). OPA is defined as the difference between systolic and diastolic IOP and represents the pulsatile wave front produced by the varying amount of blood in the eye during the cardiac cycle. It has been shown to vary with ocular structural parameters, such as axial length, corneal thickness, and ocular rigidity, as well as with systemic variables like heart rate, blood pressure, and left ventricular ejection fraction. Although the existence of some of these associations is still controversial, the clinical relevance of OPA has been consistently suggested, especially in glaucoma. Further research on this intriguing parameter could not only provide insight into glaucoma pathophysiology but also help integrate this variable into clinical practice.

The eye resembles a pressurized globe that is subject to expansile forces generated by the rhythmic filling of intraocular vessels during the cardiac cycle. The fluctuation in ocular blood volume leads to an oscillating variation in intraocular pressure (IOP) that is counterbalanced by the resistance to distention of the ocular outer shell [1]. These oscillations are represented by the ocular pulse amplitude (OPA) and are displayed in an ocular pulse wave that can be recorded via continuous measurement techniques, such as dynamic contour tonometry (DCT) [1,2]. By recording the pulsatile component of the ocular blood flow over a period of time, the OPA may provide an indirect measurement of the uveal blood volume changes during the cardiac cycle, as the choroid represents most of the ocular blood volume and receives 80-90% of the local flow [3]. Accordingly, OPA has been proposed as an index of ocular hemodynamics [4,5]. Furthermore, it has been suggested as a surrogate outcome for extraocular hemodynamics, the rationale being that anything that interferes with ocular perfusion will likely affect OPA measurements. This includes local factors as well as distant diseases like, for instance, carotid artery stenosis (CAS) [6]. Moreover, the OPA might also depend on ocular characteristics linked to compliance of the outer layers. For example, IOP measurement with a Goldmann applanation tonometer (GAT) is significantly influenced by the central corneal thickness (CCT), whereas when using a DCT - and thus avoiding applanation - the CCT would play a lesser role in IOP assessment [1,7]. Other, non-CCT-related factors, such as the IOP level, scleral thickness, ocular elasticity, axial length (AL), and lens status, could influence OPA measurements [7,8,9]. As the characteristics and the pathophysiological variability of OPA remain partially unclear, several researchers are attempting to answer these open questions and find clinically useful applications. As expected, much of this research is being done in glaucoma patients, since both mechanical damage due to an elevated IOP and a higher susceptibility due to altered ocular hemodynamics are thought to contribute to disease progression [10,11]. As changes in diagnosis and treatment strategies might depend on small differences in the measured IOP, it is of crucial importance to approximate the real IOP as closely as possible. Anterior chamber manometry is a very accurate but invasive method to determine IOP and hence is rarely used [12]. As the gold-standard GAT readings are significantly influenced by CCT (which can per se be an independent risk factor for disease progression), an increasing number of centers are using DCT to bypass that important limitation. While its use may have its caveats, such as interobserver reproducibility, it does provide intriguing additional information on ocular hemodynamics which may be of clinical relevance in glaucoma management [13].

The intent of this review is to present an overview of the current knowledge about using DCT and OPA, with emphasis on its application in glaucoma.

DCT represents a relatively new technology for noninvasive IOP measurement that uses the principle of ‘contour matching'. Its function is described by the Pascal principle, referring to an equality of the pressures acting on the anterior corneal surface at the time of measurement:

FIOP + Fr + Fc + Fap = 0,

where IOP is the actual aqueous pressure, r refers to ocular rigidity (OR), c to capillary attraction, and ap to a potential appositional element [1]. It uses a miniature piezoresistive pressure sensor embedded within a tonometer tip which approximates the cornea's shape when the pressures on both sides are equal (fig. 1). Therefore, this measurement is less dependent on the effect of interindividual variation on corneal properties, in contrast to applanation tonometry [1,7]. This is an important difference, since all forms of applanation tonometry use variable force-to-pressure translations, whereas the DCT always measures using a constant force. When, subsequently, the sensor is subjected to a change in pressure, the electrical resistance is altered and the computer of the DCT calculates a change in pressure in concordance with the change in resistance.

Fig. 1

Ocular pulse wave measured with DCT. OPA is the numerical representation of the difference between the minimum (broken line) and maximum (dotted line) of the pulse wave contour. Adapted from Kaufmann et al. [2].

Fig. 1

Ocular pulse wave measured with DCT. OPA is the numerical representation of the difference between the minimum (broken line) and maximum (dotted line) of the pulse wave contour. Adapted from Kaufmann et al. [2].

Close modal

Another difference is that it measures IOP in a continuous way and provides a pressure curve that is synchronous with the cardiac cycle (fig. 2). These pulsatile variations in IOP are thought to be caused by the amount of blood that is pumped into the eye, mainly in the choriocapillary bed, during each systole [1]. The computer calculates the average IOP and gives the range of pulsation amplitude, together with a score for the quality of the measurement. Continuous measurement implies apposition of the measurement probe for an extended period (∼8 s). Accordingly, some have reported that DCT measurements are significantly more time-consuming and more difficult to perform than GAT in routine practice, and that most eyes require repeated DCT measurements [14]. In contrast, the acoustic signal of the DCT that informs the examiner about the correct alignment and continuous measurement seems to encourage patients to remain still for the time needed.

Fig. 2

Schematic representation of the DCT method. Adapted from Parikh and Parikh [70].

Fig. 2

Schematic representation of the DCT method. Adapted from Parikh and Parikh [70].

Close modal

GAT is an analogous technique where the clinician uses a force to flatten a circular surface (3.06 mm in diameter) of the central cornea and interprets the alignment of 2 hemicircles formed at the interface [15]. This measurement is thus dependent on corneal rigidity, since more force will be needed to flatten a thick cornea regardless of the actual IOP [16,17]. Furthermore, it will only measure the IOP at a particular moment, not during a prolonged interval. This technique is time-efficient and less patient dependent than DCT [18]. Accordingly, GAT is currently considered the gold standard to measure and report IOP [19]. To reduce the error inherently linked to interindividual differences in CCT, researchers have proposed a correction of formulas [20]. These are not uniformly accepted or validated but do indicate the need for a more independent noninvasive method for IOP measurement.

Higher IOP values have been reported using DCT versus GAT, while others have found this to be true only in patients with low CCT values [21,22,23,24,25]. In fact, no statistically significant influence of anterior segment parameters on DCT-assessed IOP has been detected. Moreover, DCT measurements have shown a good concordance with anterior chamber manometry, in contrast to GAT-determined IOP values [1,2,8,26]. Several studies have examined the differences between DCT and GAT according to corneal morphology [7,22,25]. An increased disparity in IOP readings between GAT and DCT has been reported in patients with very high or very low CCT [25]. These findings are important, as the Ocular Hypertension Treatment Study (OHTS) showed CCT to be a significant risk factor for the development of glaucoma in patients with ocular hypertension. It showed that patients with a CCT below 555 µm had a 3 times greater risk of developing primary open-angle glaucoma (POAG) than patients with a CCT above 588 µm [28,29]. There are several possible explanations for the association between CCT and glaucoma risk, and one of them is that a thinner cornea may be associated with a more flexible corneoscleral shell which could be more sensitive to IOP-induced stress. Iatrogenically changing CCT by either increasing it - by performing Descemet's stripping endothelial keratoplasty - or decreasing it following a LASIK (laser-assisted in situ keratomileusis) procedure does influence IOP measurements [7,30,31,32,33]. Following LASIK, the IOP decreased using GAT measurements but was unchanged when assessed with DCT [7,33]. Furthermore, less intra- and interobserver variability was reported for DCT with respect to GAT, also demonstrating DCT measurements to be more repeatable and reproducible [27]. The better reproducibility of the DCT may result in more precise measurements for monitoring IOP changes over time.

Glaucoma is thought to affect more than 80 million people worldwide [34]. It is a neurodegenerative disease that causes irreversible blindness and has a massive economic impact related to both treatment costs and the burden on care providers. The diagnosis is based on assessment of the visual field and imaging of the optic nerve head, with IOP being of paramount importance in disease management [35]. The mainstay of treatment remains lowering the IOP in order to prevent disease progression. Although very effective pharmaceuticals, laser treatments, and filtering surgery techniques have been described, a significant number of patients still show signs of disease progression despite excellent IOP control [36]. Some patients have proven to be more susceptible to the development of glaucomatous damage, even when the IOP falls within the normal range. This finding directed researchers to investigate other factors besides IOP alone in the pathogenesis of glaucoma. Multiple studies have shown the importance of vascular dysregulation in glaucoma patients, since they are more prone to having lower ocular perfusion pressures, more often peripheral vasospasms and migraine, low retrobulbar flow velocities, and decreased OPA [37,38,39]. There are several noninvasive ways to investigate ocular blood flow-related variables. DCT with determination of OPA, color Doppler imaging of the retrobulbar circulation, Doppler optical coherence tomography, enhanced depth imaging optical coherence tomography for choroidal thickness measurements, and retinal oximetry are methods that provide information about bulbar perfusion and oxygenation [40,41,42,43,44,45]. However, the therapeutic impact of these measurements remains unclear.

Researchers have reported significantly lower OPA values in glaucoma patients versus age-matched healthy individuals [44,45]. In addition, OPA has also been correlated with more severe glaucomatous damage in POAG patients after controlling for IOP [46]. These lower OPA readings could indicate a decrease in choroidal flow, already suggested to exist in glaucoma [47,48].

Using Doppler analysis to evaluate ocular blood flow and its variables, our research group speculated that OPA reflects the vascular resistance of the retrobulbar vessels in healthy subjects but not in glaucoma patients [44]. Moreover, there appears to be a reduction in retrobulbar flow velocities in glaucoma patients. These results were confirmed using Doppler waveform analysis, which suggested that the relationship between OPA and both systemic and ocular vascular parameters was weaker in POAG and normal tension glaucoma (NTG) compared to healthy controls [45]. This may suggest that in glaucoma patients other nonvascular variables may be important determinants of OPA, probably related to the biomechanical properties of the ocular compartment walls. The influence of these properties on OPA measurements could thus be more relevant in glaucoma patients than in healthy individuals. This is in agreement with previous reports that have failed to prove any correlation between OPA and vascular systemic and ocular parameters in glaucoma patients [50]. Several studies have reported the influence of the globe's structure on OPA [2,51]. Kaufmann et al. [2] found OPA not to be influenced by the structure of the anterior segment (CCT, corneal curvature, and anterior chamber depth). These findings were confirmed by Ishii et al. [51], but there was a significant correlation with IOP, AL, and peripheral corneal thickness 4 mm away from the corneal center. The latter observation is believed to be due to the effects of the probe configuration on measurements with DCT - the central part of the cornea is closely approached, so the movements of the central cornea are limited and peripheral corneal thickness could be important in pulse propagation or contribute to the outer shell stiffness.

OPA and OR

To quantify the compliance of the globe, researchers introduced OR. It refers to the relationship between the extensibility in function of an IOP change and has been used as a clinical concept that characterizes the biomechanical properties of the ocular wall [52,53]. However, the pressure-volume relation does not conform to a simple law, and several mathematical formulations have been proposed to quantify it. The one proposed by Friedenwald [54] uses the OR coefficient (E) based on a logarithmic pressure-volume relationship:

E = (log IOP1 - log IOP2)/(V1 - V2),

where the slope of the log-transformed pressure-volume relationship of the eye is the coefficient of OR (E) [54]. A higher E value signifies that the eye is stiffer, with a consequently larger increase in pressure (IOP) as the volume (V) increases; a lower E signifies a less stiff eye, with a smaller increase in IOP for the same volume increase. Other than the method of the OR coefficient of Friedenwald [54], other authors have proposed equations that include anterior chamber manometry, AL changes, measurement of pulse amplitude and fundus vessel pulsations, ultrasound elastography, and evaluation of corneal hysteresis [52]. However, there are some drawbacks for most of these methodologies, such as poor accuracy or reproducibility, technical complexity, and, above all, invasive measurement techniques [52,55,56]. Recently, Wang et al. [49] used a noninvasive technique to estimate OR in vivo. Substituting OPA and pulsatile ocular blood flow (POBF) with ΔIOP and ΔV, respectively, into the equation of Friedenwald [54], an estimation of E (Er) was calculated. The Er calculated via this method using DCT and laser Doppler flowmetry was lowest in glaucoma patients and highest in OHT subjects. This supports the idea that a more compliant ocular shell may predispose the optic nerve head to IOP-related damage. Some authors have suggested the OR to be the link between the mechanical and vascular hypotheses for glaucoma pathogenesis [57]. Especially deformation of the lamina cribrosa and subsequent kinking of the pores might influence the axonal flow and cause metabolic stress [58]. Its clinical use has been limited due to difficulties in performing accurate measurements, but the advent of new modalities such as ultrasound elastography for ocular tissues may enable the use of an OR index in glaucoma management. DCT with OPA determination could help in defining a measure for OR.

OPA and AL

Another important factor influencing OPA is the AL [51,56]. This is illustrated by the observation that a defined blood volume change in the choroid results in a smaller relative change in pressure in myopic eyes than in shorter emmetropic eyes [5,56]. In addition, the reduced scleral rigidity in myopic eyes results in less resistance to enlargement of the pulsatile volume [59]. Moreover, a longer AL implicates a longer distance to travel by the pulse wave, possibly resulting in dampening of the wave as it passes through various tissues. Furthermore, myopia itself serves as a risk factor for glaucoma [60].

OPA and Ocular Blood Flow

Although many advocate OPA as an estimate for POBF, the interpretation of OPA as a direct measure of POBF is not straightforward. OPA reflects a change in pressure induced by the varying ocular blood volume during the cardiac cycle. Furthermore, since ocular perfusion is inversely related to IOP and (following the equation of Friedenwald [54]) OPA is directly related to IOP, it follows that OPA may not to be regarded as a direct measure for POBF [44,61]. This has been illustrated by numerous reports indicating no relationship between blood pressure, heart rate, and OPA, although the left-ventricular ejection time has shown a correlation with OPA [5,50]. Interestingly, when investigating the difference between POAG and NTG, Abegão Pinto et al. [45] reported OPA to be correlated with retrobulbar flow in the former group, whereas OPA was correlated with systemic hemodynamic measures in the latter diagnostic group. This is in agreement with previous reports that in NTG patients vascular dysregulation is prominent [62]. When looking at patients with CAS, responsible for decreasing blood flow and oxygen delivery to the eye, researchers have reported OPA to be linked to the severity of the occlusion [63]. Especially when comparing OPA between eyes in unilateral CAS, the predictive value is significantly increased. Therefore, OPA could serve as a screening tool for unilateral CAS. Since CAS serves as a risk factor for developing asymmetrical glaucomatous damage, OPA could aid in narrowing down the differential diagnosis. This also illustrates that various vascular related disorders could influence OPA and could be linked to the development of glaucoma.

OPA and Filtering Surgery

Trabeculectomy is performed to decrease IOP and stabilize glaucomatous optic neuropathy. A decrease in OPA has been reported after trabeculectomy. However, those investigators did not correct for changes in IOP [64]. Others have found no change in OPA when correcting the outcome for IOP changes [65]. Besides the drop in IOP following trabeculectomy, changes in OR might influence OPA measurements. By creating a partial-thickness scleral flap, ocular biomechanical properties might change significantly. Detorakis et al. [66] reported a greater difference between GAT and DCT IOP measurements following trabeculectomy versus IOP-matched untreated eyes. Other surgical interventions possibly influence OPA by inducing changes in OR. Researchers have reported no change in OPA following Descemet's stripping endothelial keratoplasty [30,31,32]. Probably because the graft is not anchored to the sclera, the influence on OR is limited. LASIK did not seem to influence the OPA either [33]. After scleral buckling for retinal detachment repair, the OPA did decrease significantly [9].

Besides the properties of the ocular wall, the content of the eye might also play a role since the pressure pulse needs to travel from the posterior pole to the cornea. Various investigators have found no difference in OPA following cataract surgery [67,68,69]. Lens status apparently does not affect OR or pulse propagation to an extent sufficient to alter OPA readings.

The DCT, which is a relatively new contact type tonometer, can simultaneously measure OPA and IOP. OPA is believed to be derived from changes in ocular blood volume secondary to POBF during the cardiac cycle. Based on published reports, it has been suggested that OPA may add value in the diagnosis and follow-up of glaucoma. Low OPA values are found in glaucoma patients, especially in those suffering from NTG, and are correlated with more severe visual field defects. Furthermore, there is evidence that OPA also depends strongly on OR, which has also been reported to be altered in glaucoma patients. Future studies are needed both to improve our understanding of how OPA is influenced by several ocular and systemic variables and to define its clinical relevance in daily glaucoma management.

Schematic Overview of Published Research on OPA

The authors have no ethical conflicts to disclose.

The authors have no conflicts of interest to disclose.

1.
Punjabi OS, Kniestedt C, Stamper RL, Lin SC: Dynamic contour tonometry: principle and use. Clin Experiment Ophthalmol 2006;34:837-840.
2.
Kaufmann C, Bachmann LM, Robert YC, Thiel MA: Ocular pulse amplitude in healthy subjects as measured by dynamic contour tonometry. Arch Ophthalmol 2006;124:1104-1108.
3.
Alm A, Bill A: Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res 1973;15:15-29.
4.
Pourjavan S, Boëlle P-Y, Detry-Morel M, De Potter P: Physiological diurnal variability and characteristics of the ocular pulse amplitude (OPA) with the dynamic contour tonometer (DCT-Pascal). Int Ophthalmol 2007;27:357-360.
5.
Grieshaber MC, Katamay R, Gugleta K, Kochkorov A, Flammer J, Orgül S: Relationship between ocular pulse amplitude and systemic blood pressure measurements. Acta Ophthalmol 2009;87:329-334.
6.
Knecht PB, Menghini M, Bachmann LM, Baumgartner RW, Landau K: The ocular pulse amplitude as a noninvasive parameter for carotid artery stenosis screening: a test accuracy study. Ophthalmology 2012;119:1244-1249.
7.
Kaufmann C: Intraocular pressure measurements using dynamic contour tonometry after laser in situ keratomileusis. Invest Ophthalmol Vis Sci 2003;44:3790-3794.
8.
Kirstein EM, Elsheikh A, Gunvant P: Tonometry - past, present and future; in Gunvant P (ed): Glaucoma - Current Clinical and Research Aspects. InTech, Rijeka, 2005.
9.
Katsimpris JM, Petropoulos IK, Pournaras CJ: Ocular pulse amplitude measurement after retinal detachment surgery. Klin Monatsbl Augenheilkd 2003;220:127-130.
10.
Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Stefánsson E: The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002;21:359-393.
11.
Burgoyne CF, Downs JC, Bellezza AJ, Suh JKF, Hart RT: The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005;24:39-73.
12.
Coleman DJ, Trokel S: Direct-recorded intraocular pressure variations in a human subject. Arch Ophthalmol 1969;82:637-640.
13.
Kotecha A, Elkarmouty A, Ajtony C, Barton K: Interobserver agreement using Goldmann applanation tonometry and dynamic contour tonometry: comparing ophthalmologists, nurses and technicians. Br J Ophthalmol 2015, Epub ahead of print.
14.
Kaufmann C, Bachmann LM, Thiel MA: Comparison of dynamic contour tonometry with Goldmann applanation tonometry. Invest Ophthalmol Vis Sci 2004;45:3118-3121.
15.
Schmidt TA: The clinical application of the Goldmann applanation tonometer. Am J Ophthalmol 1960;49:967-978.
16.
Whitacre MM, Stein RA, Hassanein K: The effect of corneal thickness on applanation tonometry. Am J Ophthalmol 1993;115:592-596.
17.
Congdon NG, Broman AT, Bandeen-Roche K, Grover D, Quigley HA: Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol 2006;141:868-875.
18.
Schneider E, Grehn F: Intraocular pressure measurement - comparison of dynamic contour tonometry and Goldmann applanation tonometry. J Glaucoma 2006;15:2-6.
19.
Cook JA, Botello AP, Elders A, Ali A, Azuara-Blanco A, Fraser C; Surveillance of Ocular Hypertension Study Group: Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 2012;119:1552-1557.
20.
Brandt JD: Corneal thickness in glaucoma screening, diagnosis, and management. Curr Opin Ophthalmol 2004;15:85-89.
21.
Erickson DH, Goodwin D, Rollins M, Belaustegui A, Anderson C: Comparison of dynamic contour tonometry and Goldmann applanation tonometry and their relationship to corneal properties, refractive error, and ocular pulse amplitude. J Am Optom Assoc 2009;80:169-174.
22.
Costin BR, Fleming GP, Weber PA, Mahmoud AM, Roberts CJ: Corneal biomechanical properties affect Goldmann applanation tonometry in primary open-angle glaucoma. J Glaucoma 2014;23:69-74.
23.
Özcura F, Yildirim N, Şahin A, Çolak E: Comparison of Goldmann applanation tonometry, rebound tonometry and dynamic contour tonometry in normal and glaucomatous eyes. Int J Ophthalmol 2015;8:299-304.
24.
Anderson MF, Agius-Fernandez A, Kaye SB: Comparison of the utility of Pascal dynamic contour tonometry with Goldmann applanation tonometry in routine clinical practice. J Glaucoma 2013;22:422-426.
25.
Francis BA, Hsieh A, Lai M-Y, et al: Effects of corneal thickness, corneal curvature, and intraocular pressure level on Goldmann applanation tonometry and dynamic contour tonometry. Ophthalmology 2007;114:20-26.
26.
Boehm AG, Weber A, Pillunat LE, Koch R, Spoerl E: Dynamic contour tonometry in comparison to intracameral IOP measurements. Invest Ophthalmol Vis Sci 2008;49:2472-2477.
27.
Deokule S, Vizzeri G, Medeiros FA: Repeatability and reproducibility of Goldmann applanation, dynamic contour, and ocular response analyzer tonometry. J Glaucoma 2013;22:127-132.
28.
Herndon LW, Weizer JS, Stinnett SS: Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004;122:17-21.
29.
Johnson CA, Keltner JL, Miller JP, Parish RK 2nd, Wilson MR: The Ocular Hypertension Treatment Study. Arch Ophthalmol 2002;120:714-720.
30.
Price FW, Price MO: Descemet's stripping with endothelial keratoplasty in 200 eyes: early challenges and techniques to enhance donor adherence. J Cataract Refract Surg 2006;32:411-418.
31.
Vajaranant TS, Price MO, Price FW, Wilensky JT, Edward DP: Intraocular pressure measurements following Descemet stripping endothelial keratoplasty. Am J Ophthalmol 2008;145:780-786.
32.
Jivrajka R, Schultz KL, Price MO, et al: Ocular pulse amplitude in patients with Descemet stripping endothelial keratoplasty. J Glaucoma 2014;23:142-144.
33.
Pepose JS, Feigenbaum SK, Qazi MA, Sanderson JP, Roberts CJ: Changes in corneal biomechanics and intraocular pressure following LASIK using static, dynamic, and noncontact tonometry. Am J Ophthalmol 2007;143:39-47.
34.
Kingman S: Glaucoma is second leading cause of blindness globally. Bull World Health Organ 2004;82:887-888.
35.
Jampel HD: Target pressure in glaucoma therapy. J Glaucoma 1997;6:133-138.
36.
Weinreb RN, Aung T, Medeiros FA: The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311:1901-1911.
37.
Flammer J, Mozaffarieh M: What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol 2007;52:S162-S173.
38.
Broadway DC, Drance SM: Glaucoma and vasospasm. Br J Ophthalmol 1998;82:862-870.
39.
Stalmans I, Harris A, Vanbellinghen V, Zeyen T, Siesky B: Ocular pulse amplitude in normal tension and primary open angle glaucoma. J Glaucoma 2008;17:403-407.
40.
Boeckaert J, Vandewalle E, Stalmans I: Oximetry: recent insights into retinal vasopathies and glaucoma. Bull Soc Belge Ophtalmol 2012;319:75-83.
41.
Park HYL, Jeon SH, Park CK: Enhanced depth imaging detects lamina cribrosa thickness differences in normal tension glaucoma and primary open-angle glaucoma. Ophthalmology 2012;119:10-20.
42.
Van Keer K, Abegão Pinto L, Willekens K, Stalmans I, Vandewalle E: Correlation between peripapillary choroidal thickness and retinal vessel oxygen saturation in young healthy individuals and glaucoma patients. Invest Ophthalmol Vis Sci 2015;56:3758-3762.
43.
Cherecheanu AP, Garhofer G, Schmidl D, Werkmeister R, Schmetterer L: Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol 2013;13:36-42.
44.
Stalmans I, Harris A, Fieuws S, Zeyen T, Vanbellinghen V, Siesky B: Color Doppler imaging and ocular pulse amplitude in glaucomatous and healthy eyes. Eur J Ophthalmol 2009;19:580-587.
45.
Abegão Pinto L, Vandewalle E, Willekens K, Marques-Neves C, Stalmans I: Ocular pulse amplitude and Doppler waveform analysis in glaucoma patients. Acta Ophthalmol 2014;92:e280-e285.
46.
Vulsteke C, Stalmans I, Fieuws S, Zeyen T: Correlation between ocular pulse amplitude measured by dynamic contour tonometer and visual field defects. Graefes Arch Clin Exp Ophthalmol 2008;246:559-565.
47.
Samra WA, Pournaras C, Riva C, Emarah M: Choroidal hemodynamic in myopic patients with and without primary open-angle glaucoma. Acta Ophthalmol 2013;91:371-375.
48.
Marangoni D, Falsini B, Colotto A, et al: Subfoveal choroidal blood flow and central retinal function in early glaucoma. Acta Ophthalmol 2012;90:e288-e294.
49.
Wang J, Freeman EE, Descovich D, Harasymowycz PJ, Kamdeu Fansi A, Li G, Lesk MR: Estimation of ocular rigidity in glaucoma using ocular pulse amplitude and pulsatile choroidal blood flow. Invest Ophthalmol Vis Sci 2013;54:1706-1711.
50.
Choi J, Lee J, Park SB, Lee KS, Sung KR, Kook MS: Factors affecting ocular pulse amplitude in eyes with open angle glaucoma and glaucoma-suspect eyes. Acta Ophthalmol 2012;90:552-558.
51.
Ishii K, Mori M, Oshika T: An evaluation of the effects of eyeball structure on ocular pulse amplitude in healthy subjects. Int Ophthalmol 2012;32:553-557.
52.
Detorakis ET, Pallikaris IG: Ocular rigidity: biomechanical role, in vivo measurements and clinical significance. Clin Experiment Ophthalmol 2013;41:73-81.
53.
Dastiridou AI, Ginis HS, De Brouwere D, Tsilimbaris MK, Pallikaris IG: Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure. Invest Ophthalmol Vis Sci 2009;50:5718-5722.
54.
Friedenwald JS: Contribution to the theory and practice of tonometry. Am J Ophthalmol 1937;20:985-1024.
55.
Dastiridou AI, Tsironi EE, Tsilimbaris MK, et al: Ocular rigidity, outflow facility, ocular pulse amplitude, and pulsatile ocular blood flow in open-angle glaucoma: a manometric study. Invest Ophthalmol Vis Sci 2013;54:4571-4577.
56.
Dastiridou AI, Ginis H, Tsilimbaris M, et al: Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of axial length. Invest Ophthalmol Vis Sci 2013;54:2087-2092.
57.
Ethier CR: Scleral biomechanics and glaucoma - a connection? Can J Ophthalmol 2006;41:9-14.
58.
Quigley HA, Hohman RM, Addicks EM, Massof RW, Green WR: Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol 1983;95:673-691.
59.
McBrien NA, Jobling AI, Gentle A: Biomechanics of the sclera in myopia: extracellular and cellular factors. Optom Vis Sci 2009;86:E23-E30.
60.
Mitchell P, Hourihan F, Sandbach J, Wang JJ: The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999;106:2010-2015.
61.
Guidoboni G, Harris A, Cassani S, et al: Intraocular pressure, blood pressure, and retinal blood flow autoregulation: a mathematical model to clarify their relationship and clinical relevance. Invest Ophthalmol Vis Sci 2014;55:4105-4118.
62.
Galassi F, Giambene B, Varriale R: Systemic vascular dysregulation and retrobulbar hemodynamics in normal-tension glaucoma. Invest Ophthalmol Vis Sci 2011;52:4467-4471.
63.
Knecht PB, Menghini M, Bachmann LM, Baumgartner RW, Landau K: The ocular pulse amplitude as a noninvasive parameter for carotid artery stenosis screening: a test accuracy study. Ophthalmology 2012;119:1244-1249.
64.
Von Schulthess SR, Kaufmann C, Bachmann LM, Yanar A, Thiel MA: Ocular pulse amplitude after trabeculectomy. Graefes Arch Clin Exp Ophthalmol 2006;244:46-51.
65.
Breusegem C, Fieuws S, Zeyen T, Stalmans I: The effect of trabeculectomy on ocular pulse amplitude. Invest Ophthalmol Vis Sci 2010;51:231-235.
66.
Detorakis ET, Grammenandi E, Pallikaris IG, Tsilimbaris MK: Differences between Goldmann applanation tonometry and dynamic contour tonometry following trabeculectomy. J Ophthalmol 2010, DOI: 10.1155/ 2010/357387.
67.
Plange N, Rennings C, Herr A, et al: Ocular pulse amplitude before and after cataract surgery. Curr Eye Res 2012;37:115-119.
68.
Tabuchi H, Kiuchi Y, Ohsugi H, Nakakura S, Han Z: Effects of corneal thickness and axial length on intraocular pressure and ocular pulse amplitude before and after cataract surgery. Can J Ophthalmol 2011;46:242-246.
69.
Turk A, Mollamehmetoglu S, Imamoglu HI, Kola M, Erdol H, Akyol N: Effects of phacoemulsification surgery on ocular hemodynamics. Int J Ophthalmol 2013;6:537-541.
70.
Parikh S, Parikh R: IOP and target IOP. J Curr Glaucoma Pract 2010;4:37-43.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.